Indian MedTech Company Makes a Global Mark at PCR London Valves 2025
Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25,…
Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the PARADIGM Trial)
MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) --…
